VIVUS Taking Out New Highs (VVUS)
VIVUS Inc. (NASDAQ: VVUS) is soaring on what is already exponential volume. The company’s interim update showed that patients taking Qnexa reduced their weight by up to 14.7% on average in one trial,...
View ArticleArena Not Good Enough, VIVUS Likes It (ARNA, VVUS)
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) came out with its news that it plans to submit its new drug ppplication for lorcaserin to the FDA in December after its one-year BLOSSOM trial met all primary...
View ArticleVIVUS Up Again on Data (VVUS)
VIVUS Inc. (NASDAQ: VVUS) is trading up this morning on additional data on its Qnexa, the obesity investigational drug candidate with data being presented at the annual scientific meeting of The...
View ArticleVIVUS Mounting (VVUS)
VIVUS Inc. (NASDAQ: VVUS) is popping up hard this morning as the company may soon have a new erectile dysfunction drug on the market if the test results lead to an FDA approval. It announced positive...
View ArticleVIVUS Submits NDA (VVUS)
VIVUS, Inc. (NASDAQ: VVUS) is trading higher this morning after the company announced that it has submitted its Qnexa new drug application to the FDA for the treatment of obesity. This also includes...
View ArticleVIVUS Options Signaling Huge Move (VVUS)
VIVUS, Inc. (NASDAQL VVUS) shares closed up strong on the week with a 21% gain despite a somewhat soft move Friday. An analyst call from Wedbush and a downgrade the following day ahead of the FDA...
View ArticleVivus Weight Loss Drug Effective Over Two Year Period
Vivus Inc. (NASDAQ: VVUS) is up 9.55% to $6.77 in pre-market trading following an announcement that the company’s experimental weight loss drug, Qnexa, helped overweight people lose an average of 11.4%...
View ArticleUnusual Options Patterns For What Lies Ahead (AA, BRCD, HAL, VVUS, UNG, SIRI)
We have scanned the options trades for highly unusual options trading patterns from Friday to see which will be carryover issues into next week. Some may seem logical, while some may seem odd....
View ArticleWeekend Review of Unusual Options Trading (ACOR, CAAS, GME, HK, S, TEVA, VVUS)
Each Saturday we usually try to do a review of some unusual options trading at the end of the week. With Friday being expiration date, that can always mask some of the larger trades. We tracked...
View Article
More Pages to Explore .....